Joshua Fitch is the senior editor for Contemporary Pediatrics.He joined the brand in March of 2023 as an editor before being promoted to senior editor in January 2024. Fitch graduated from Youngstown ...

Allergies can significantly impair daily activities, school performance, and psychological well-being.

Six-month results from the phase 2 VLA1553-221 trial aligned with initial data and demonstrated immune response at day 180 among patients aged 1 to 11 years.

Get caught up with Contemporary Pediatrics! This list helps you navigate our top stories from the week, all in one place.

Results at 24 weeks revealed that 76% of individuals achieved a 75% or more improvement in overall disease severity (EASI-75), trial's primary endpoint. Among a study population of adults and ...

Aaron Milstone, MD, emphasizes the need for better recognition and prevention of Staphylococcus aureus infections in neonatal intensive care units. Despite decades of scientific progress, invasive ...

According to the study authors, transcatheter (percutaneous) closure of the PDA has increased across centers with advances in technology and optimized venous retrograde approaches. In 2019, the FDA ...

Aaron Milstone, MD, explains that very low birth weight infants remain disproportionately affected by deadly Staph aureus infections in NICUs. Invasive Staphylococcus aureus infections remain a major ...

Six-month results from the phase 2 VLA1553-221 trial aligned with initial data and demonstrated immune response at day 180 among patients aged 1 to 11 years. Among children aged 1 to 11 years, new ...

BillionToOne has unveiled a broader version of its UNITY Fetal Risk Screen, now capable of identifying fetal risk for 14 different recessive and X-linked genetic conditions. The update expands the ...

Infant is closely monitored at subsequent well visits and rechecked after 3 months, showed full resolution of the skin lesion over the heel area. A healthy 12-month-old girl presented with one small ...

The AI-enabled, wearable device is the first FDA-approved, drug-free solution for nasal congestion and allergies in children ages 12 and up. The FDA has approved an expanded pediatric indication for ...